Results 91 to 100 of about 50,069 (258)

Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada

BMC Public Health
Background Benzodiazepines are a class of medications that are being frequently prescribed in Canada but carry significant risk of harm. There has been increasing clinical interest on the potential “sparing effects” of medical cannabis as one strategy to
Cerina Dubois, Heidi Fernandes, Mu Lin, Karen J. B. Martins, Jason R. B. Dyck, Scott W. Klarenbach, Lawrence Richer, Ed Jess, John G. Hanlon, Elaine Hyshka, Dean T. Eurich   +10 more
doaj   +1 more source

Contingency management interventions for substance use and addictive behaviours: Review of the United Kingdom evidence base

Addiction, EarlyView.
Abstract Background and aims Substance use and other addictive behaviours including gambling remain major public health concerns in the UK. Despite the effectiveness of substance use treatment approaches, treatment adherence and success rates remain low.
Carol‐Ann Getty, Tricia McQuarrie, Eileen Brobbin   +2 more
wiley   +1 more source

Drug use among people in prison: A global review of epidemiology, harms and interventions

Addiction, EarlyView.
Abstract Background and aims People who use drugs are overrepresented in the criminal justice system. We aimed to provide a broad synthesis of the epidemiology, harms and interventions related to drug use and drug use disorders among incarcerated adults worldwide, and highlight gaps in evidence and practice.
Louis Favril, John Strang, Seena Fazel
wiley   +1 more source

Alcohol approach–avoidance task behavior and brain potentials differentially predict ecologically assessed alcohol craving and consumption in early emerging adulthood

Addiction, EarlyView.
Abstract Aims The current study measured the extent to which different neurobehavioral indices of incentive‐motivational salience attribution to alcohol cues predict alcohol craving and consumption in the natural environment. Design, setting, and participants Laboratory study at a university in Missouri, USA, followed by a smartphone‐based 21‐day ...
Roberto U. Cofresí, Sandie Keerstock, Casey B. Kohen, Thomas M. Piasecki, Bruce D. Bartholow   +4 more
wiley   +1 more source

Medical Cannabis

Annals of Emergency Medicine, 2019
Jørgen G, Bramness, Vigdis, Vindenes
openaire   +4 more sources

Exploring the genetic overlap between substance use disorder and educational attainment

Addiction, EarlyView.
Abstract Background and aims Substance use disorder (SUD) is a polygenic psychiatric condition characterized by persistent drug use despite negative consequences. Several studies support that higher cognitive performance and educational attainment (EA) are associated with a reduced risk for SUD.
Judit Cabana‐Domínguez, Laura Vilar‐Ribó, María Soler Artigas, Silvia Alemany, Natalia Llonga, Pau Carabí‐Gassol, Uxue Zubizarreta‐Arruti, Valeria Macias‐Chimborazo, Lara Grau‐López, Constanza Daigre, Elena Ros‐Cucurull, Raúl Felipe Palma‐Alvarez, Germán Ortega‐Hernández, Noèlia Fernàndez‐Castillo, Bru Cormand, Josep Antoni Ramos‐Quiroga, Marta Ribasés   +16 more
wiley   +1 more source

Medical cannabis for chronic pain [PDF]

BMJ, 2021
Edeltraut, Kröger, Clermont E, Dionne
openaire   +2 more sources

Commentary on Borodovsky et al.: Enhancing research on THC quantification—Consumer awareness through accurate labelling

Addiction, Volume 120, Issue 4, Page 686-687, April 2025.
Rachel Lees Thorne, Tom P. Freeman
wiley   +1 more source

Estimating thresholds for risk of cannabis use disorder using standard delta‐9‐tetrahydrocannabinol (THC) units

Addiction, EarlyView.
Abstract Background and aims Lower risk guidelines for safer levels of cannabis use could help to reduce the health burden posed by cannabis use disorder (CUD). We aimed to estimate risk thresholds for CUD based on delta‐9‐tetrahydrocannabinol (THC) consumption using standard THC units (1 unit = 5 mg THC).
Rachel Lees Thorne, Will Lawn, Kat Petrilli, Katie Trinci, Anya Borissova, Shelan Ofori, Claire Mokrysz, H. Valerie Curran, Lindsey A. Hines, Tom P. Freeman   +9 more
wiley   +1 more source

Associations between county‐level e‐cigarette‐inclusive Tobacco 21 law population coverage and e‐cigarette use behaviors among United States adolescents in Monitoring the Future

Addiction, EarlyView.
Abstract Background and aims In the United States (US), Tobacco 21 (T21) laws set the minimum legal sale age for all tobacco products to 21 years. This study aimed to examine whether e‐cigarette‐inclusive T21 laws were associated with e‐cigarette use behaviors and related disparities among US adolescents.
James H. Buszkiewicz, Catherine A. Vander Woude, Yanmei Xie, Steven Cook, Bukola Usidame Peters, Megan E. Patrick, Michael R. Elliott, James F. Thrasher, Nancy L. Fleischer   +8 more
wiley   +1 more source